Alentic

BARDA continues biodosimetry partnership through agreement to develop triage diagnostic for initial evaluation of radiation exposure

Alan — Thu, 06 Oct 2022 13:45:58 +0000

BARDA is continuing its partnership to develop fieldable diagnostics to rapidly identify individual exposures to ionizing radiation following a nuclear or radiological incident. Rapid triaging of casualties is a key component of the public health and medical response to guide treatment, preserve scarce resources, and alleviate public concern. Currently, no diagnostic tool is available to quickly identify persons that need acute medical care following an ionizing radiation incident.

Canadian innovators advance in the Deep Space Healthcare Challenge

Alan — Wed, 25 May 2022 14:01:10 +0000

Longueuil, Quebec, May 25, 2022 — The Canadian Space Agency (CSA) and Impact Canada have selected the 20 semi-finalists for the Deep Space Healthcare Challenge, a competition to develop innovative healthcare technologies for people living in remote communities now, and crews on long-duration space missions in the future.

The teams selected by the Deep Space Healthcare Challenge jury will receive $30,000 in prize money and advance to Stage 2. In the second stage, semi-finalists will build a proof-of-concept that can generate data in a lab environment.

How machine learning is revolutionizing medical research in Nova Scotia and beyond

Alan — Sun, 07 Feb 2021 00:00:29 +0000

“With all this big data … it just surpasses humans’ ability to comprehend what is going on’

David Burke – CBC News

Advanced computer programs that use machine learning are transforming the way medical research is done in Nova Scotia and around the world.

Work that might have taken years to complete, or would have been astronomically expensive, can now be done faster and at lower cost.

Analyze This: Space Station Facility Enables Rapid Biomedical Analysis

Alan — Mon, 13 May 2019 00:00:13 +0000

In its role as a unique orbiting laboratory, the International Space Station provides a broad range of equipment for conducting health and life sciences research. However, the equipment available for cellular and molecular biology is limited compared to capabilities found in laboratories on Earth. To address this limitation, the Canadian Space Agency (CSA) commissioned an innovative biomedical device for an upcoming space station expedition. The videogame console-sized Bio-Analyzer enables near real time, onboard analysis using freshly collected biological samples such as blood, urine, saliva, sweat, and cell cultures.

Bio-Analyzer: Near-real-time biomedical results from space to Earth

Alan — Thu, 09 May 2019 00:00:45 +0000

The Bio-Analyzer is a new tool the size of a videogame console that astronauts aboard the International Space Station (ISS) will use to easily test different body fluids such as blood, saliva, and urine. Using just a few drops of liquid—no big needles required!—it quickly returns key biomedical analyses.

ACOA lends $3 million to develop portable lab

Alan — Wed, 24 Apr 2019 00:00:46 +0000

The Atlantic Canada Opportunities Agency is providing a $2.99 million loan to Alentic Microscience Inc., which has devised a pocket-sized diagnostic device that can generate test results in under five minutes, from any location, using only a drop of blood from a pinprick.

In collaboration with Honeywell International Inc., Alentic obtained a multi-million dollar contract with the Canadian Space Agency to develop specific diagnostic tests and a device to monitor astronauts’ immune systems in real time, according to a news release by the Atlantic Canada Opportunities Agency.

Halifax-made blood testing device heading to International Space Station

Alan — Tue, 05 Mar 2019 00:00:57 +0000

A Halifax medical technology company that believes it has discovered the holy grail in rapid diagnostic blood testing is getting nearly $3 million from the federal government.

Led by Dalhousie University neuroscientist and founder Alan Fine, Alentic Microsciences has patented a hand-held device that can analyze a tiny amount of blood, producing test results on the spot almost immediately.

“It is going to produce health-care benefits for the public at large. It is going to lower the costs of delivery of health care,” Fine told CBC News Monday, after the company received a $2.92-million loan from the Atlantic Canada Opportunities Agency.

Alentic Lands $3M from ACOA

Alan — Tue, 05 Mar 2019 00:00:03 +0000

A team of researchers in Halifax are on the brink of releasing a pocket-sized medical device that can generate test results in mere minutes, using only a pinprick of blood.

Alentic Microscience is a Halifax-based microscopy company that has developed a new imaging device that instantly reads patients’ results at the point of care, using only a drop of fluid, without the need for bulky microscopes and lab equipment.

On Monday, the company was granted a $2,992,162 loan from the Atlantic Canada Opportunities Agency’s Business Development Program to commercialize its device.

Halifax firm improves lives and provides faster results with new technology

Alan — Mon, 04 Mar 2019 00:00:44 +0000

News release
Alentic Microscience Inc. commercializes its blood diagnostic device for medical settings
March 4, 2019 – Halifax, NS – Atlantic Canada Opportunities Agency

Cutting-edge ideas in life sciences are reaching the marketplace faster than ever, providing Canadians with less invasive and more effective treatment options that improve patient outcomes. Determined to provide mobile healthcare solutions that give immediate results, Alentic Microscience Inc. has developed a pocket-sized diagnostic device that can generate test results in under five minutes, from any location, using only a drop of blood from a pinprick.

ACOA loan helps Alentic commercialize device

Alan — Mon, 04 Mar 2019 00:00:43 +0000

Alentic Microscience Inc. of Halifax has developed a pocket-sized diagnostic device that can generate test results in under five minutes, from any location, using only a drop of blood from a pinprick.

In collaboration with Honeywell International Inc., Alentic successfully obtained a multi-million dollar contract with the Canadian Space Agency to develop specific diagnostic tests and a device to monitor astronauts’ immune systems in real time, which was previously impossible, according to a news release by the Atlantic Canada Opportunities Agency.

On Monday it was announced that ACOA would provide the company with $2,992,162 loan through its Business Development Program.